Tirzepatide: Mounjaro: Originally approved for type 2 diabetes but is showing promise in clinical trials for weight loss
The third FDA-approved indication, granted in 2024, is for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity
The resistant potato starch in GLP-1 Complete supports this pancreatic pathway through two routes
Wegovy is approved for chronic weight management, offering benefits such as regulating appetite, slowing digestion, and lowering blood pressure and cholesterol levels
What I don't like: The price is steep for budget-conscious individuals and those with a tight budget
(For small-molecule drugs like semaglutide, at least seven years must have passed from its FDA approval date to be eligible for selection, and for drugs with multiple FDA approvals, CMS will use the earliest approval date to make this determination.) If that happens, a negotiated Medicare price would be available beginning in 2027